KATHRYN SAVAGE: Open Payments
NPI 1538897517 · RICHMOND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 40 payments from 15 companies in 2025. Trend: 2023 $19 · 2024 $527 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $110 |
| GlaxoSmithKline, LLC. | 6 | $104 |
| ABBVIE INC. | 5 | $94 |
| Corcept Therapeutics | 5 | $89 |
| Dexcom, Inc. | 3 | $85 |
| Lilly USA, LLC | 4 | $60 |
| Mallinckrodt Hospital Products Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $23 |
Products named: TRELEGY ELLIPTA, Korlym, Dexcom G6 Transmitter, VRAYLAR, Ozempic, MOUNJARO, ACTHAR, Wegovy.
Industry payments across KY — which companies pay providers there.
